Imugene Limited

30 April 2008	Quarterly Activities Update and Appendix 4C
07 April 2008	Cocci Vaccine Trial in Progress
29 February 2008	Half Yearly Report and Accounts
06 February 2008	Change of Director’s Interest Notice
06 February 2008	Change of Director’s Interest Notice
04 February 2008	Form 603 - Notice of initial substantial holder
01 February 2008	Change of Directors' Interests x3
31 January 2008	Appendix 3B - New Issue Announcement
31 January 2008	Quarterly Report to 31 December 2007
22 January 2008	Allotment Of Rights Issue Shares, Appendix 3B And s708A Notice
18 January 2008	Rights Issue - Notification of Shortfall
17 December 2007	Letter to Shareholders
11 December 2007	Non-Renounceable Rights Issue
03 December 2007	Appendix 3B - New Issue Announcement
03 December 2007	Non-Renounceable Rights Issue
27 November 2007	Results of AGM
27 November 2007	AGM Chairman's Address
05 November 2007	Imugene patent protection in China and Korea
31 October 2007	Expiry of Unlisted Options
31 October 2007	Quarterly Report to 30 September 2007
25 October 2007	Annual Report to Shareholders
25 October 2007	Notice of Annual General Meeting/Proxy Form
18 October 2007	PRRS vaccine trial preliminary results
12 October 2007	Imugene patent protection extended
26 September 2007	Financial Report for YE 30 June 2007
25 September 2007	Imugene to develop new vaccines
30 August 2007	Preliminary final report - Year ended 30 June 2007
31 July 2007	Quarterly Report to 30 June 2007
18 July 2007	Imugene’s pig PRRS vaccine trial commences in US
13 June 2007	FINSIA Healthcare Forum presentation
30 May 2007	Imugene strengthens patent protection
21 May 2007	Imugene avian influenza poultry vaccine reaches 100% efficacy in US trials
30 April 2007	Quarterly Report to 31 March 2007
14 March 2007	Imugene avian influenza vaccine update
27 February 2007	Financial Report for the Half-Year Ended 31 December 2006
31 January 2007	Quarterly Report to 31 December 2006
29 January 2007	Imugene avian influenza vaccine success in US trials
25 January 2007	Imugene avian influenza vaccine trial update
18 January 2007	Appendix 3B - New issue announcement
18 January 2007	Results of General Meeting
17 January 2007	Imugene avian influenza vaccine trial update
15 December 2006	Imugene avian influenza vaccine moves to final trial stages
14 December 2006	Notice of General Meeting
14 December 2006	Management Incentive Options
29 November 2006	Chairman's Address - 2006 AGM
29 November 2006	Results of Annual General Meeting
14 November 2006	Poultry product progresses in Merial development program
08 November 2006	Imugene offered $880,000 grant to develop bird flu vaccines for poultry
31 October 2006	Quarterly report for July - September 2006
30 October 2006	Avian influenza vaccine efficacy trials to begin late November
26 October 2006	Notice of Annual General Meeting
26 October 2006	Annual Report 2006
20 October 2006	Poultry Productivity Enhancer Passes Further Safety Trials
18 September 2006	Financial Report- Yead ended 30 June 2006
13 September 2006	Preliminary Final Report- Yead ended 30 June 2006
24 August 2006	Two avian influenza vaccine candidates finalised.
31 July 2006	Quarterly report for April - June 2006
17 July 2006	Imugene strengthens poultry patent protection
10 July 2006	US Patent Interference Proceeding to be Resolved in Favour of Imugene
4 July 2006	Poultry Productivity Enhancer Passes Safety Tests
31 May 2006	Poultry Productivity Enhancer – Product Safety Trial
28 April 2006	Quarterly report for January - March 2006
16 March 2006	Shareholder update and 31 December 2005 half-year accounts
13 March 2006	New Trial Commences for Lead Poultry Product
7 March 2006	Imugene Opens New Research Laboratory Facility at La Trobe University
31 January 2006	Quarterly report for October - December 2005
30 January 2006	Imugene Granted Licence from Gene Regulator for Poultry Growth Product
6 December 2005	Imugene Partners with Multinational to Construct New Poultry Vaccine
24 November 2005	Results of Annual General Meeting 2005
24 November 2005	Chairman's Address 2005 Annual General Meeting
31 October 2005	Market Update & Quarterly Report Period Ending 30 September 2005
25 October 2005	Annual Report 2005
21 October 2005	Notice of Annual General Meeting
13 October 2005	Imugene Licenses Poultry Productivity Product to Merial
27 July 2005	Imugene Quarterly Report for Period Ending 30 June 2005
21 February 2005	Half Yearly Report
16 February 2005	Imugene Investment Briefing
17 January 2005	Receptor Mimic Technology Patent Granted in United States
11 January 2005	2005 General Meeting Results
7 December 2004	Poultry Trial - Significant Commercial Results
23 November 2004	Share Placement Release
17 November 2004	Bird Flu Vaccine back on track
16 November 2004	Key Patent granted in Japan
15 November 2004	Successful Poultry Productivity Enhancer Trials
10 November 2004	Imugene PRRS Pig Vaccine moves into Product Development Phase
8 November 2004	Imugene New Appointments
25 October 2004	2005 Annual Report
25 October 2004	Quarterly report for Period Ending 30 September 2004
18 October 2004	Avian Influenza Trial Results
7 October 2004	ASX RMT Pig Trial Results
1 October 2004	Presentation to the Australian Biotech Expo
16 September 2004	Receptor Mimic Technology to be Commercialised for Humans
16 September 2004	Imugene Secures Receptor Mimic Technology Options for all Animal Species
24 August 2004	Avian Influenza Vaccine Effiency trials
5 August 2004	Successful Trial achieves 7% growth gain in poultry
29 July 2004	Imugene Investor Presentation
29 July 2004	Quarterly report for Period Ending 30 June 2004

ASX Announcements